Nitches Inc. Discusses Joint Venture with cGMP Facility
Analysis based on 6 articles · First reported Aug 05, 2026 · Last updated Aug 05, 2026
The announcement is a minor positive for Nitches, potentially signaling growth and new revenue opportunities, but it is preliminary and non-binding. The broader market impact is negligible given the small size of the company and the speculative nature of the discussions.
Nitches (OTCID:NICH) announced on August 5, 2026, that it is in active discussions regarding a strategic joint venture with a major U.S.-based cGMP-certified manufacturing facility. The proposed collaboration would establish Nitches and its NutraVeri platform as a dedicated marketing and customer acquisition arm, creating a streamlined pathway for brands seeking formulation, manufacturing, fulfillment, and commercialization services. If completed, the joint venture would combine NutraVeri's network of supplement brands, readiness scoring, and commercialization tools with the manufacturing expertise of the cGMP facility. CEO Dan Morgan stated that the goal is to become the front door for brands entering the nutritional supplement market. The company cautioned that there is no assurance the discussions will result in a completed transaction.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard